Diagnostic & Thrptc Cntr of Athns Hyg : HYGEIA Group – Q1 2018 Financial Results

31/05/2018

PRESS RELEASE

HYGEIA Group - Q1 2018 Financial Results

•  Consolidated EBITDA from continuing operations continued to improve, reaching €11.5m and recording a 4.5% rise.

•  Consolidated sales from continuing operations for the Group remained at high levels and amounted to €55.9m.

Within its obligation to inform the investor community, the company DIAGNOSTIC & THERAPEUTIC CENTER OF ATHENS HYGEIA SA (hereinafter HYGEIA) announced the main consolidated operating results for this 2018 quarter.

Million €	Q1 2018	Q1 2017	% Change
Group
Revenue	55.9	55.6	0.4%
EBITDA(1)	11.5	10.9	4.5%

(1) Results before taxes, financial and investment results, depreciation and amortization.

HYGEIA Hospital SA was founded in 1970 and has since been active in the provision of primary and secondary healthcare services, occupying a leading position in the private Greek healthcare sector. The Company is listed in the Athens Exchange and employs over 3,200 people and over 4,000 associate physicians. In January 2006, MARFIN INVESTMENT GROUP (MIG) gained control of the Company and launched a series of investment initiatives, with the strategic objective being to create the largest group of integrated healthcare services. HYGEIA Group owns three hospitals in Greece (HYGEIA, MITERA & LETO) and one in Albania (HYGEIA Tirana), with a total capacity of 1,094 licensed beds, 52 operating rooms, 19 delivery rooms and 10 ICUs. It also owns one Molecular Biology & Cytogenetics Center (AlfaLab) and a company trading in special materials, consumables, pharmaceuticals and general medical supplies (Y-LOGIMED). Furthermore, it is active in the area of research, production and trading of medical cosmetics (BEATIFIC).

4, Erythrou Stavrou Str. & Kifisias, GR 15123, Marousi, Athens

Τ: 210 686 7020 F: 210 686 7623www.hygeia.gr